AMOROSO, Rosa
 Distribuzione geografica
Continente #
NA - Nord America 9.387
EU - Europa 6.752
AS - Asia 6.139
SA - Sud America 604
AF - Africa 92
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 22.986
Nazione #
US - Stati Uniti d'America 9.135
SG - Singapore 2.278
CN - Cina 1.637
IT - Italia 1.311
RU - Federazione Russa 1.248
TR - Turchia 791
IE - Irlanda 789
UA - Ucraina 725
SE - Svezia 686
VN - Vietnam 586
GB - Regno Unito 521
BR - Brasile 506
FR - Francia 441
IN - India 411
DE - Germania 367
FI - Finlandia 182
PL - Polonia 160
CA - Canada 157
HK - Hong Kong 83
AT - Austria 75
BD - Bangladesh 64
ES - Italia 59
JP - Giappone 57
MX - Messico 55
NL - Olanda 42
PK - Pakistan 37
KR - Corea 35
BE - Belgio 34
ZA - Sudafrica 32
CZ - Repubblica Ceca 31
AR - Argentina 28
IQ - Iraq 26
LT - Lituania 26
VE - Venezuela 18
ID - Indonesia 17
CO - Colombia 15
DZ - Algeria 13
MY - Malesia 13
CL - Cile 12
AE - Emirati Arabi Uniti 11
GR - Grecia 11
IL - Israele 11
MA - Marocco 11
SA - Arabia Saudita 11
EC - Ecuador 10
KE - Kenya 10
TW - Taiwan 10
AU - Australia 8
PH - Filippine 8
PT - Portogallo 8
IR - Iran 7
JM - Giamaica 7
PE - Perù 7
CH - Svizzera 6
EG - Egitto 6
ET - Etiopia 6
HR - Croazia 6
JO - Giordania 6
UZ - Uzbekistan 6
DO - Repubblica Dominicana 5
TT - Trinidad e Tobago 5
AL - Albania 4
BG - Bulgaria 4
CR - Costa Rica 4
HN - Honduras 4
KZ - Kazakistan 4
PY - Paraguay 4
SY - Repubblica araba siriana 4
TN - Tunisia 4
LB - Libano 3
NP - Nepal 3
OM - Oman 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
SV - El Salvador 3
YE - Yemen 3
AZ - Azerbaigian 2
CY - Cipro 2
DK - Danimarca 2
DM - Dominica 2
EE - Estonia 2
EU - Europa 2
GT - Guatemala 2
HU - Ungheria 2
KG - Kirghizistan 2
KH - Cambogia 2
PA - Panama 2
TH - Thailandia 2
UY - Uruguay 2
ZW - Zimbabwe 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BM - Bermuda 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
Totale 22.972
Città #
Singapore 1.707
San Jose 1.065
Chandler 984
Jacksonville 833
Dublin 778
Ashburn 702
Dallas 689
Izmir 499
Beijing 383
Princeton 317
Southend 314
Dearborn 309
Chieti 284
Nanjing 236
The Dalles 222
Ann Arbor 207
Los Angeles 205
Wilmington 193
Santa Clara 190
Ho Chi Minh City 185
Cambridge 164
Council Bluffs 151
Hanoi 115
New York 115
Kraków 108
Nanchang 102
Tongling 102
Pescara 95
Houston 90
Woodbridge 89
Buffalo 85
Altamura 80
Moscow 76
Boardman 71
Hong Kong 71
Munich 67
São Paulo 63
Dong Ket 62
Vienna 61
Kocaeli 57
Hebei 55
Hefei 53
Kunming 49
Tianjin 46
Warsaw 46
Jiaxing 45
Helsinki 43
Orem 42
Redondo Beach 42
Shenyang 42
Toronto 42
Teramo 41
Tokyo 41
Bosa 40
Atlanta 39
Denver 37
Changsha 36
London 36
Montreal 36
Washington 36
Brussels 34
Da Nang 34
Jinan 34
Milan 34
Ottawa 34
Rome 34
Brooklyn 32
Chennai 32
Chicago 31
Norwalk 30
Stockholm 27
Brno 26
Poplar 26
Ningbo 24
Hangzhou 23
Nuremberg 23
Amsterdam 22
Augusta 22
Bologna 22
Frankfurt am Main 22
Seoul 22
Haiphong 21
Rio de Janeiro 21
Turku 21
Johannesburg 20
Seattle 20
Guangzhou 19
Phoenix 19
Mexico City 17
Ankara 16
Boston 16
Orange 15
San Francisco 15
Auburn Hills 14
Hải Dương 14
Mumbai 14
San Mateo 14
San Vito Chietino 14
Shanghai 14
Biên Hòa 13
Totale 13.878
Nome #
1,3-Asymmetric induction: Highly enantioselective synthesis of α-amino acids via 2,5-trans disubstituted imidazolidin-4-ones 1.237
Valutazione biologica e computazionale di inibitori della Ossido Nitrico Sintasi 251
Anticancer Activity of Stilbene-Based Derivatives 193
Synthesis of 2-aryloxypropanoic acids analogues of clofibric acid and assignment of the absolute configuration by 1H NMR spectroscopy and DFT calculations 192
Effects of dichloroacetate as single agent or in combination with GW6471 and metformin in paraganglioma cells 191
Synthesis and antibacterial evaluation of oxazolidin-2-ones structurally related to linezolid 189
Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-L-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma 188
Inhibition of PPARγ by Natural Compounds as a Promising Strategy in Obesity and Diabetes 187
Synthesis of fibrates analogues and pharmacological evaluation as PPARa agonists 182
Amidine N-sostituite come potenziali inibitori delle Ossido Nitrico Sintasi 178
Valutazione biologica dei derivati dell'acido clofibrico come potenziali ligandi PPARs 178
Sintesi di nuovi derivati dell'anello 2-ossazolidinonico: molecole di notevole interesse come ausiliari chirali e come potenziali agenti antimicrobici 177
Progettazione e sintesi di ossazolidinoni a potenziale attività antibatterica 177
Synthesis, biological activity, and docking studies of novel acetamidines as selective modulators of nitric oxide synthase 172
Titanium-Promoted Acylation of Sulfonamides to N-Acylsulfonamide PPAR Antagonists 171
Synthesis and Biological Evaluation of 2-Heteroarylthioalkanoic Acid Analogues of Clofibric Acid as Peroxisome Proliferator-Activated Receptor alfa Agonists 167
Synthesis and structure-activity relationships of fibrate-based analogues inside PPARs 167
Recent developments of amidine-like compounds as selective NOS inhibitors 167
2-Substituted Benzothiazoles as Antiproliferative Agents: Novel Insights on Structure-Activity Relationships 167
Asymmetric synthesis of (S)-ibuprofen by esterification with amides of (S)-lactic acid as chiral auxiliaries: experimental and theoretical results 165
Antiglioma Activity of Aryl and Amido-Aryl Acetamidine Derivatives Targeting iNOS: Synthesis and Biological Evaluation 164
Synthesis and biological evaluation of potential Nitric Oxide Synthase inhibitors 163
Novel Phenyldiazenyl Fibrate Analogues as PPAR α/γ/δ Pan-Agonists for the Amelioration of Metabolic Syndrome 161
Antilipemic agents: synthesis and chemical separation of chiral analogues of gemfibrozil 160
Benzothiazole-based N-(phenylsulfonyl)amides as a novel familyof PPARa antagonists 160
Synthesis of benzothiazolyl-thioalkanoic acids and pharmacological evaluation on PPARa 159
Determinazione della configurazione assoluta di acidi carbossilici a-sostituiti di interesse farmaceutico attraverso spettroscopia NMR 159
Cytotoxic effect of a family of Peroxisome Proliferator-Activated Receptor antagonists in colorectal and pancreatic cancer cell lines 159
Synthesis and antiplatelet activity of gemfibrozil chiral analogues 157
Candida rugosa lipase-catalysed kinetic resolution of 2-substituted-aryloxyacetic esters with dimethylsulfoxide and isopropanol as additives 157
Asymmetric Synthesis of Arylpropionic Acids and Aryloxy Acids by Using Lactamides as Chiral Auxiliaries 157
Discovery of new FXR agonists based on 6-ECDCA binding properties by virtual screening and molecular docking 157
The Selective Acetamidine-Based iNOS Inhibitor CM544 Reduces Glioma Cell Proliferation by Enhancing PARP-1 Cleavage In Vitro 157
Anti-Inflammatory, Antioxidant, and WAT/BAT-Conversion Stimulation Induced by Novel PPAR Ligands: Results from Ex Vivo and In Vitro Studies 156
Enantiomeric separation of Gemfibrozil chiral analogues by capillary electrophoresis with heptakis(2,3,6-tri-O-methyl)-beta-cyclodextrin as chiral selector 156
Direct resolution of α-monoalkyl-α-aryloxyacetic acids via ester or imide derivatives 156
Blocking the Peroxisome Proliferator-Activated Receptor (PPAR): An Overview 156
Asymmetric synthesis of enantiomerically enriched chiral fibrates, thiols and aminoacids 153
Development of a Rapid Mass Spectrometric Determination of AMP and Cyclic AMP for PDE3 Activity Study: Application and Computational Analysis for Evaluating the Effect of a Novel 2-oxo-1,2-dihydropyridine-3-carbonitrile Derivative as PDE-3 Inhibitor 153
Resveratrol Derivative Exhibits Marked Antiproliferative Actions, Affecting Stemness in Pancreatic Cancer Cells 152
Emerging Effects of Resveratrol Derivatives in Cells Involved in Oral Wound Healing: A Preliminary Study 151
Sintesi ed attività antibatterica di 3-cinnamoil e 3-piridinilossazolidin -2-oni 151
Chiral analogues of clofibrate: dynamic kinetic resolution via 2-bromoimides 150
Synthesis and biological evaluation of gemfibrozil chiral analogs as potential PPARa agonists 150
Synthesis of diastereomerically enriched 2-bromoesters and their reaction with nucleophiles 150
Druggability profile of stilbene-derived PPAR agonists: Determination of physicochemical properties and PAMPA study 150
PPARα agonists based on stilbene and its bioisosteres: Biological evaluation and docking studies 148
The Benzimidazole-Based Anthelmintic Parbendazole: A Repurposed Drug Candidate That Synergizes with Gemcitabine in Pancreatic Cancer 148
Syntesis and pharmacological evaluation of fibrates analogues as cardiovascular agents 146
Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitors 146
Fibrate-derived N-(methylsulfonyl)amides with antagonistic properties on PPARa 145
4-Substituted prolines, useful reagents in enantioselective synthesis and conformational restraints in bioactive peptidomimetics design 145
Synthesis and cytotoxic effects on pancreatic cancer cells of resveratrol analogs 144
Synthesis and antiplatelet activity of thioaryloxyacids analogues of clofibric acid 143
Synthesis and antiplatelet activity of clofibric acid analogues 141
Antiplatelet activity of gemfibrozil chiral analogues 141
Sintesi e valutazione biologica di analoghi eterociclici del gemfibrozil a potenziale attività cardiovascolare 141
Synthesis, biological evaluation and docking studies of N-substituted acetamidines as selective inhibitors of inducible nitric oxide synthase 139
Indazole, Pyrazole, and Oxazole Derivatives Targeting Nitric Oxide Synthases and Carbonic Anhydrases 139
N-acylsulfonamides: synthetic routes and biological potential in medicinal chemistry 139
Sulfonimide and Amide Derivatives as Novel PPARα Antagonists: Synthesis, Antiproliferative Activity, and Docking Studies 137
Synthesis of naphthyl-, quinolin- and anthracenyl analogues of clofibric acid as PPARα agonists 136
Synthesis and biological evaluation of new acetamidines as selective inhibitors of Nitric Oxide Synthases 134
Selective Acetamidine-Based Nitric Oxide Synthase Inhibitors: Synthesis, Docking, and Biological Studies 134
Amidine-Based Compounds Affecting L-Arginine Metabolism 134
The anticancer potential of Peroxisome Proliferator-Activated Receptor antagonists 134
Sintesi di analoghi chirali del gemfibrozil 2,5,disostituiti a potenziale attività antiaggregante piastrinica 133
Synthesis of chiral a-substituted β-amino acids starting from 6-alkylperihydropyrimidin-4-ones 133
Selective inhibition of inducible Nitric Oxide Synthase by derivatives of acetamidine 133
Optically active 2-substituted carboxylic acids isosters of fibrates by 2-bromo esters 132
Novel aminobenzyl-acetamidine derivative modulate the differential regulation of NOSs in LPS induced inflammatory response: Role of PI3K/Akt pathway 132
Fibrate-based N-acylsulphonamides targeting carbonic anhydrases: synthesis, biochemical evaluation, and docking studies 131
Discovery of gemfibrozil analogues that activate PPARa and enhance the expression of gene CPT1A involved in fatty acids catabolism 130
Starting a new series of acetamidines as Nitric Oxide Sinthase inhibitors 129
Amidine-Based Bioactive Compounds for the Regulation of Arginine Metabolism 129
Time factor in antiretroviral adherence: analysis of adherence to single-tablet regimens versus multiple-tablet regimens over a 5-year period 129
Dynamic kinetic resolution of α-bromoesters containing lactamides as chiral auxiliaries 128
Analoghi eterociclici dell’acido clofibrico: sintesi, attività antiaggregante piastrinica e separazione in elettroforesi capillare 128
null 128
Synthesis, characterization and evaluation of gemfibrozil-stilbene hybrid as antioxidant agent 128
Multitarget PPARγ agonists as innovative modulators of the metabolic syndrome 128
Structural development studies of PPARs ligands based on tyrosine scaffold 127
Synthesis and biological evaluation of novel acetamidines as nitric oxide inhibitors 126
Seeking for Non-Zinc-Binding MMP-2 Inhibitors: Synthesis, Biological Evaluation and Molecular Modelling Studies 126
The excitation-contraction coupling on C2C12 skeletal muscle myotubes was modulated by NO-donor ester of gemfibrozil 126
Advancements in the Research of New Modulators of Nitric Oxide Synthases Activity 125
Benzothiazole Derivatives Endowed with Antiproliferative Activity in Paraganglioma and Pancreatic Cancer Cells: Structure-Activity Relationship Studies and Target Prediction Analysis 125
Dual-PPAR agonists based on stilbene scaffold: synthesis and biological evaluation 125
Selective Inhibition of iNOS by Benzyl- and Dibenzyl Derivatives of N-(3-Aminobenzyl)acetamidine. 124
N-Substituted acetamidines and 2-methylimidazole derivatives as selective inhibitors of neuronal nitric oxide synthase 123
Sintesi di esteri del gemfibrozil donatori di ossido nitrico 123
Targeting neuronal nitric oxide synthase as a valuable strategy for the therapy of neurological disorders 123
Chiral derivatives of clofibrate: direct resolution via ester or imide derivatives 122
Platelet aggregation: synthesis and pharmacological evaluation of clofibric acid analogues 121
Design, synthesis and biological activity of selective hCAs inhibitors based on 2-(benzylsulfinyl)benzoic acid scaffold 121
Isosteres of chiral clofibric acid analogs: synthesis, resolution, absolute configuration and HPLC detection of the optical purity 120
Effect of stilbene and chalcone scaffolds incorporation in clofibric acid on PPARα agonistic activity 120
Selective inhibition of iNOS by benzyl- and dibenzyl derivatives of N-(3-aminobenzyl)acetamidine on cellular line H2C9 119
Effect of milrinone analogues on intracellular calcium increase on single living H9C2 cells 119
Development of Fibrates as Important Scaffolds in Medicinal Chemistry 119
Totale 15.849
Categoria #
all - tutte 85.181
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.181


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021132 0 0 0 0 0 0 0 0 0 0 0 132
2021/2022976 23 14 31 148 108 26 37 80 122 38 113 236
2022/20232.795 208 368 190 297 263 548 146 226 356 33 90 70
2023/20241.296 101 46 110 38 80 401 297 28 7 45 15 128
2024/20253.300 143 626 516 76 57 143 196 171 288 166 443 475
2025/20268.046 557 287 960 923 739 417 1.242 494 1.390 558 363 116
Totale 23.910